Click here to hear insights from EDBI’s Head of Emerging Technology, Dr Basil Lui on Panel: Investors Perspectives on Autonomous Mobility.
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
- 05 03 2025
- |